会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 61. 发明授权
    • High performance solution processable semiconductor based on dithieno [2,3-D:2′, 3′-D′]benzo[1,2-B:4,5-B′] dithiophene
    • 基于二噻吩[2,3-D:2',3'-D']苯并[1,2-B:4,5-B']二噻吩的高性能溶液可加工半导体
    • US08367717B2
    • 2013-02-05
    • US13002208
    • 2009-06-25
    • Marcel KastlerSilke KoehlerKlaus MuellenPeng GaoDirk BeckmannXinliang FengHoi Nok Tsao
    • Marcel KastlerSilke KoehlerKlaus MuellenPeng GaoDirk BeckmannXinliang FengHoi Nok Tsao
    • A61K31/38C07D333/50
    • H01L51/0074C07D495/22C09K11/06C09K2211/1011C09K2211/1092G02B2006/12069H01L51/0545H01L51/5048H05B33/10H05B33/14Y02E10/549
    • Dithienobenzodithiophenes of general formula (I) in which R1 to R6 are each independently selected from a) H, b) halogen, c) —CN, d) —NO2, e) —OH, f) a C1-20 alkyl group, g) a C2-20 alkenyl group, h) a C2-20 alkynyl group, i) a C1-20 alkoxy group, j) a C1-20 alkylthio group, k) a C1-20 haloalkyl group, I) a —Y—C3-10 cycloalkyl group, m) a —Y—C6-14 aryl group, n) a —Y-3-12 membered cyclo-heteroalkyl group, or o) a —Y-5-14 membered heteroaryl group, wherein each of the C1-20 alkyl group, the C2-20 alkenyl group, the C2-20 alkynyl group, the C3-10 cycloalkyl group, the C6-14 aryl group, the 3-12 membered cyc-loheteroalkyl group, and the 5-14 membered heteroaryl group is optionally substituted with 1-4 R7 groups, wherein R1 and R3 and R2 and R4 may also together form an aliphatic cyclic moiety, Y is independently selected from divalent a C1-6 alkyl group, a divalent C1-6 haloalkyl group, or a covalent bond; and m is independently selected from 0, 1, or 2. The invention also relates to the use of the dithienobenzodithiophenes according to any of claims 1 to 4 as semiconductors or charge transport materials, as thin-film transistors (TFTs), or in semiconductor components for organic light-emitting diodes (OLEDs), for photovoltaic components or in sensors, as an electrode material in batteries, as optical waveguides or for electrophotography applications.
    • 通式(I)的二噻吩并苯并二噻吩,其中R 1至R 6各自独立地选自a)H,b)卤素,c)-CN,d)-NO 2,e)-OH,f)C 1-20烷基, )C2-20烯基,h)C2-20炔基,i)C1-20烷氧基,j)C1-20烷硫基,k)C1-20卤代烷基,I)a -Y- C3-10环烷基,m)-Y-C6-14芳基,n)a -Y-3-12元环杂烷基,或o)-Y-5-14元杂芳基,其中各 C 1-20烷基,C 2-20烯基,C 2-20炔基,C 3-10环烷基,C 6-14芳基,3-12元环 - 卤杂烷基和5-14 任选被1-4个R 7基团取代,其中R 1和R 3以及R 2和R 4也可以一起形成脂族环状部分,Y独立地选自二价C 1-6烷基,二价C 1-6卤代烷基 ,或共价键; 并且m独立地选自0,1或2.本发明还涉及根据权利要求1至4中任一项所述的二噻吩并苯并噻吩作为半导体或电荷传输材料,作为薄膜晶体管(TFT)或半导体 用于有机发光二极管(OLED)的组件,用于光伏组件或传感器,作为电池中的电极材料,作为光波导或电子照相应用。
    • 62. 发明授权
    • Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors
    • 含有以二硫烷基和氨基肽酶N抑制剂形式的二硫烷基的氨基酸衍生物
    • US08247608B2
    • 2012-08-21
    • US12084091
    • 2006-10-24
    • Bernard RoquesMarie-Claude Fournie-Zaluski
    • Bernard RoquesMarie-Claude Fournie-Zaluski
    • C07C321/00C07C323/00C07C381/00C07C211/00A61K31/38
    • C07C323/60C07D333/24
    • The invention relates to novel compounds of formula (I): H2N—CH(R1)—CH2—S—S—CH2—CH(R2)—CONH—R5, wherein R1 is a hydrocarbon chain, phenyl or benzyl radical, methylene radical substituted by a 5 or 6 atom heterocycle; R2 is a phenyl or benzyl radical, a 5 or 6 atom aromatic heterocycle, methylene group substituted by a 5 or 6 atom heterocycle; R5 is a CH(R3)—COOR4 radical, wherein R3 is hydrogen, an OH or OR group, a saturated hydrocarbon group, a phenyl or benzyl radical and OR4 is hydrophile ester, or 5 or 6 membered heterocycle comprising several heteroatoms selected from a group consisting of nitrogen, sulphur and oxygen, with at least two nitrogene atoms, wherein said heterocycle is substitutable by an alkyl C1-C6, phenyl or benzyl radical. The use of the inventive compounds in the form of drugs, a pharmaceutical composition comprising said compounds, a pharmaceutically acceptable excipient, the use in conjunction of at least one type of cannabinoid derivative for potentiating the analgesic and antidepressant effect of the novel compounds of formula (I) and/or morphine or the derivatives thereof are also disclosed.
    • 本发明涉及新的式(I)化合物:H 2 N-CH(R 1)-CH 2 -S-S-CH 2 -CH(R 2)-CONH-R 5,其中R 1是烃链,苯基或苄基,亚甲基 被5或6个原子杂环取代; R2是苯基或苄基,5或6个芳族杂环,被5或6个杂原子取代的亚甲基; R 5是CH(R 3)-COOR 4基团,其中R 3是氢,OH或OR基团,饱和烃基,苯基或苄基,OR 4是亲水酯,或包含若干个杂原子的5或6元杂环, 由氮,硫和氧组成的组,具有至少两个氮原子,其中所述杂环可被C 1 -C 6烷基,苯基或苄基取代。 药物形式的本发明化合物的使用,包含所述化合物的药物组合物,药学上可接受的赋形剂,联合至少一种类型的大麻素衍生物的用途,用于增强新型式(III)化合物的镇痛作用和抗抑郁作用 I)和/或吗啡或其衍生物也被公开。